Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • US markets stall as prices look expensive
    • Market Update

    US markets stall as prices look expensive

    The XJO is expected to open lower this morning following a night of very little movement in the U.S overnight. Their futures have edged into the red, so it seems likely that their market is tentative heading into the Fed meeting tonight. Our market yesterday bounced intraday from our all-time resistance level, giving up roughly

    Read More
    Public
  • Fluence halts Israel operations, posts best quarter performance in Q4 CY23
    • News

    Fluence halts Israel operations, posts best quarter performance in Q4 CY23

    After zooming out and reviewing the Company’s strategic moves, wastewater solutions company Fluence (ASX: FLC) took a new approach to CY23, highlighting new products and strategic realignments. And the results seem to be returning a major thumbs up. Q4 CY23 marked Fluence’s strongest financial and operational quarter of the year. The quarter saw revenues of

    Read More
    Public
  • Novatti’s strategic moves pave the way for positive cash flow amidst $4m in cost reductions
    • News

    Novatti’s strategic moves pave the way for positive cash flow amidst $4m in cost reductions

    Just six months after undertaking a leadership transition to install a leading digital payment executive Mark Healy at the helm of Novatti Group (ASX: NOV), the Melbourne-based fintech has a clear line of sight to positive cash flow having undertaken an internal restructure.  Novatti has strategically positioned itself to achieve its ambitious cash flow positive

    Read More
    Public
  • New products, new partnerships: EZZ sees sales growth in Q2 FY24
    • News

    New products, new partnerships: EZZ sees sales growth in Q2 FY24

    Genomic life science company EZZ Life Science Holdings Limited (ASX: EZZ) has demonstrated strong financial performance in the second quarter of FY24, with a focus on key health challenges and strategic expansions. EZZ closed Q2 FY24 with $13.6 million in cash inflows from customers, marking a 57% increase from the same quarter last year and

    Read More
    Public
  • Archer Materials primed to deliver on chip tech milestones and manufacturing runs
    • News

    Archer Materials primed to deliver on chip tech milestones and manufacturing runs

    If you’re somewhat versed in the tech world, you have probably heard terms like semiconductors, quantum computing and bioelectronics, and their potential to change the world. While some companies might suggest that these have a long way to go before they are usable by the layman, Archer Materials is readying to inject them into our

    Read More
    Public
  • Renewed online focus proves profitable for Mosaic, sees 50% NPAT growth in H1 FY24
    • News

    Renewed online focus proves profitable for Mosaic, sees 50% NPAT growth in H1 FY24

    Even as discretionary spending takes a hit, fashion retail company Mosaic Brands (ASX: MOZ) has come out strong, ending the first half of FY24 with a 50% increase in its Net Profit After Tax (NPAT) on PCP. As per its recently released unaudited trading update, the Company expects to report an approximate NPAT of $5.9

    Read More
    Public
  • «
  • ‹
  • 124
  • 125
  • 126
  • 127
  • 128
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.